<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01209806</url>
  </required_header>
  <id_info>
    <org_study_id>#09D.472</org_study_id>
    <nct_id>NCT01209806</nct_id>
  </id_info>
  <brief_title>The Effects of Moviprep With Simethicone on Colonic Bubbles</brief_title>
  <official_title>The Effects of Moviprep With Simethicone on Colonic Bubbles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the administration of PEG along with
      simethicone will reduce the incidence of colonic bubbles that interfere with polyp detection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      evaluating if simethicone is better than placebo at decreasing gas in the colon at time of
      colonoscopy so that it is easier for the endoscopist to see polyps
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy - Entire colon</measure>
    <time_frame>At time of colonoscopy</time_frame>
    <description>Successful cleansing defined as score or excellent or good Unsuccessful cleansing defined as score of fair or inadequate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy - Right colon</measure>
    <time_frame>At time of colonoscopy</time_frame>
    <description>Successful cleansing defined as score or excellent or good Unsuccessful cleansing defined as score of fair or inadequate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenoma detection</measure>
    <time_frame>at time of colonoscopy</time_frame>
    <description>Defined as number of adenoma/patient Secondarily evaluate % of patients with at least 1 adenoma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flushing</measure>
    <time_frame>at time of colonoscopy</time_frame>
    <description>Defined as need for any (1, 2, or 3) flushing
• 0 = none, 1 = &lt;50 ml, 2 = 50-100 ml, 3 = &gt;100 ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance</measure>
    <time_frame>during prep ingestion</time_frame>
    <description>Prep completion
• Completion defined as consuming &gt; 90%
Sleep
Primary definition as quality of sleep
Also evaluate duration of sleep Overall satisfaction
Use visual analogue (Likert) scale Adverse events - nausea, vomiting, abdominal pain, bloating, light-headedness
Primary is incidence
Secondary is severity using Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>at time of colonoscopy</time_frame>
    <description>Vitals with orthostatic measures (BP, Pulse) day of colonoscopy Physical exam</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Bubbles in Colon at Time of Colonoscopy</condition>
  <arm_group>
    <arm_group_label>simethicone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>no simethicone</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>simethicone</intervention_name>
    <description>400 mg simethicone at 6pm night prior to colonoscopy 400 mg simethicone 4 hours before colonoscopy</description>
    <arm_group_label>simethicone</arm_group_label>
    <other_name>Alka-Seltzer® Gas Relief Maximum Strength Softgels®</other_name>
    <other_name>Flatulex® Drops</other_name>
    <other_name>GasAid® Maximum Strength Softgels®</other_name>
    <other_name>Gas-X®</other_name>
    <other_name>Gas-X® Extra Strength</other_name>
    <other_name>Gas-X® Extra Strength Liquid</other_name>
    <other_name>Gas-X® Extra Strength Softgels®</other_name>
    <other_name>Genasyme®</other_name>
    <other_name>Genasyme® Drops</other_name>
    <other_name>Maalox® Anti-Gas Extra Strength</other_name>
    <other_name>Maalox® Anti-Gas Regular Strength</other_name>
    <other_name>Mylanta® Gas Relief</other_name>
    <other_name>Mylanta® Gas Relief Gelcaps®</other_name>
    <other_name>Mylanta® Gas Relief Maximum Strength</other_name>
    <other_name>Mylicon® Infant's Drops</other_name>
    <other_name>Phazyme® Infant Drops</other_name>
    <other_name>Phazyme®-125 Softgels®</other_name>
    <other_name>Phazyme®-166 Maximum Strength</other_name>
    <other_name>Phazyme®-166 Maximum Strength Softgels®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Elective outpatients undergoing colonoscopy using split dose PEG-ELS with sodium ascorbate
        and ascorbic acid

        Exclusion Criteria:

          -  Unable or unwilling to give informed consent

          -  Age &lt; 18 years

          -  Pregnant

          -  Breast feeding

          -  Established or suspected gastroparesis

          -  Pseudo-obstruction - established or suspected

          -  Severe constipation (&lt; 1 BM a week)

          -  Bowel obstruction

          -  Greater than 50% resection of colon

          -  Chronic nausea or vomiting

          -  Consumed &gt; 100% standard dose of PEG-ELS (i.e. more than 2L)

          -  G6PD deficiency

          -  PEG allergy

          -  Significant psychiatric illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Kastenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2010</study_first_submitted>
  <study_first_submitted_qc>September 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2010</study_first_posted>
  <last_update_submitted>December 5, 2014</last_update_submitted>
  <last_update_submitted_qc>December 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simethicone</mesh_term>
    <mesh_term>Aluminum hydroxide, magnesium hydroxide, drug combination</mesh_term>
    <mesh_term>Aluminum hydroxide, magnesium hydroxide, simethicone drug combination</mesh_term>
    <mesh_term>TEMPO</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

